Pathogen inactivation in labile blood products transfusion safety and economic impact - Discussion

被引：0
|
作者：
Bourel, Michel
Caen, Jacques
Dirreimer, Guy
Vacheron, Andre
Sansonetti, Philippe
Michel-Briand, Yvon
机构：
来源：
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2006年 / 190卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 188
页数：3
相关论文
共 50 条
  • [21] Back to the future: A fiction dealing with pathogen inactivation of blood products
    Canellini, G.
    Tissot, J-D
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2011, 18 (5-6) : 570 - 570
  • [22] Safety of Blood Products Risk of CMV-Transmission by Transfusion of Blood Products
    Ruchalla, Elke
    TRANSFUSIONSMEDIZIN, 2013, 3 (04) : 180 - U127
  • [23] Pathogen Inactivation Technologies The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk
    Devine, Dana V.
    Schubert, Peter
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (03) : 609 - +
  • [24] Guide for transfusion of red blood cells, platelets and labile plasma products in Spain
    Weber, MA
    Montoya, AF
    Villagrán, JLG
    Vega, CM
    Arrojo, IP
    Alcaraz, NP
    Bosch, MP
    Carasa, MAV
    MEDICINA CLINICA, 1999, 113 (12): : 471 - 474
  • [25] Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology
    Yonemura, Susan
    Doane, Suzann
    Keil, Shawn
    Goodrich, Raymond
    Pidcoke, Heather
    Cardoso, Marcia
    BLOOD TRANSFUSION, 2017, 15 (04) : 357 - 364
  • [26] Pathogen inactivation of cellular blood products -: Still plenty of reason to be careful
    Caspari, G
    Gerlich, WH
    Kiefel, V
    Gürtler, L
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2005, 32 (05) : 258 - 260
  • [27] Pathogen inactivation of cellular blood products -: More security for the patient or less?
    Caspari, G
    Gerlich, WH
    Gürtler, L
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2003, 30 (06) : 261 - 263
  • [28] Impact of Platelet Pathogen Inactivation on Blood Component Utilization Inventory
    Fachini, Roberta
    Scuracchio, Patricia
    Achkar, Ruth
    Fontao-Wendel, Rita
    Wendel, Silvano
    TRANSFUSION, 2021, 61 : 48A - 49A
  • [29] Inactivation of TSE agents: safety of blood and blood-derived products
    Taylor, DM
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2003, 10 (01) : 23 - 25
  • [30] Transfusion Safety Plasmodium-Inactivation in Whole Blood: new Method
    Ruchalla, Elke
    TRANSFUSIONSMEDIZIN, 2016, 6 (03) : 107 - 107
12345